JP4389512B2 - 腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 - Google Patents
腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 Download PDFInfo
- Publication number
- JP4389512B2 JP4389512B2 JP2003280818A JP2003280818A JP4389512B2 JP 4389512 B2 JP4389512 B2 JP 4389512B2 JP 2003280818 A JP2003280818 A JP 2003280818A JP 2003280818 A JP2003280818 A JP 2003280818A JP 4389512 B2 JP4389512 B2 JP 4389512B2
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- user
- information processing
- conversation
- display
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000008451 emotion Effects 0.000 claims description 63
- 230000010365 information processing Effects 0.000 claims description 59
- 238000005259 measurement Methods 0.000 claims description 35
- 230000017531 blood circulation Effects 0.000 claims description 33
- 230000008859 change Effects 0.000 claims description 28
- 210000004243 sweat Anatomy 0.000 claims description 22
- 230000005540 biological transmission Effects 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 19
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 210000000707 wrist Anatomy 0.000 claims description 18
- 230000004424 eye movement Effects 0.000 claims description 16
- 238000004891 communication Methods 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 15
- 230000028327 secretion Effects 0.000 claims description 13
- 230000035900 sweating Effects 0.000 claims description 13
- 210000000988 bone and bone Anatomy 0.000 claims description 11
- 230000008921 facial expression Effects 0.000 claims description 7
- 238000010248 power generation Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 claims description 2
- 210000002683 foot Anatomy 0.000 claims 4
- 210000003371 toe Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 description 29
- 239000000758 substrate Substances 0.000 description 22
- 238000010586 diagram Methods 0.000 description 15
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 15
- 239000012636 effector Substances 0.000 description 14
- 230000003287 optical effect Effects 0.000 description 10
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 230000002996 emotional effect Effects 0.000 description 8
- 238000012876 topography Methods 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 210000000804 eccrine gland Anatomy 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 230000003340 mental effect Effects 0.000 description 6
- 230000033764 rhythmic process Effects 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- 241000282326 Felis catus Species 0.000 description 4
- 108060003951 Immunoglobulin Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 210000000040 apocrine gland Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 102000018358 immunoglobulin Human genes 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 3
- 101800000414 Corticotropin Proteins 0.000 description 3
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 3
- 229960000258 corticotropin Drugs 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000010291 electrical method Methods 0.000 description 2
- 210000000750 endocrine system Anatomy 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 230000000737 periodic effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000002572 Alpha-Globulins Human genes 0.000 description 1
- 108010068307 Alpha-Globulins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101000583175 Homo sapiens Prolactin-inducible protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100030350 Prolactin-inducible protein Human genes 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000002772 conduction electron Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- -1 disulfide biotin analog Chemical class 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 230000010491 emotional process Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 229940100601 interleukin-6 Drugs 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000011133 lead Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Landscapes
- User Interface Of Digital Computer (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003280818A JP4389512B2 (ja) | 2003-07-28 | 2003-07-28 | 腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003280818A JP4389512B2 (ja) | 2003-07-28 | 2003-07-28 | 腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005046305A JP2005046305A (ja) | 2005-02-24 |
| JP2005046305A5 JP2005046305A5 (enrdf_load_stackoverflow) | 2006-06-15 |
| JP4389512B2 true JP4389512B2 (ja) | 2009-12-24 |
Family
ID=34266524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003280818A Expired - Fee Related JP4389512B2 (ja) | 2003-07-28 | 2003-07-28 | 腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4389512B2 (enrdf_load_stackoverflow) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007122154A (ja) * | 2005-10-25 | 2007-05-17 | Kozo Nagata | サプライチェーンのソリューションシステム及びソリューション方法 |
| JP2008119198A (ja) * | 2006-11-10 | 2008-05-29 | Tokai Rika Co Ltd | 状況改善助言装置 |
| JP5061931B2 (ja) * | 2008-02-04 | 2012-10-31 | ソニー株式会社 | 情報処理装置および情報処理方法 |
| US8715178B2 (en) * | 2010-02-18 | 2014-05-06 | Bank Of America Corporation | Wearable badge with sensor |
| US9138186B2 (en) | 2010-02-18 | 2015-09-22 | Bank Of America Corporation | Systems for inducing change in a performance characteristic |
| US8715179B2 (en) * | 2010-02-18 | 2014-05-06 | Bank Of America Corporation | Call center quality management tool |
| CN103339926A (zh) * | 2011-11-24 | 2013-10-02 | 株式会社Ntt都科摩 | 表情输出装置和表情输出方法 |
| JP5929145B2 (ja) * | 2011-12-07 | 2016-06-01 | 株式会社ニコン | 電子機器、情報処理方法およびプログラム |
| ITUD20120024A1 (it) * | 2012-02-15 | 2013-08-16 | Qbell Technology S P A | Dispositivo elettronico visuale emozionale |
| US20130237867A1 (en) * | 2012-03-07 | 2013-09-12 | Neurosky, Inc. | Modular user-exchangeable accessory for bio-signal controlled mechanism |
| JPWO2014129212A1 (ja) * | 2013-02-22 | 2017-02-02 | ソニー株式会社 | 画像表示装置及び画像表示方法、記憶媒体、並びにモニタリング・システム |
| US9213044B2 (en) * | 2013-10-14 | 2015-12-15 | Nokia Technologies Oy | Deviational plane wrist input |
| JP6665790B2 (ja) * | 2015-01-14 | 2020-03-13 | ソニー株式会社 | ナビゲーションシステム、クライアント端末装置、制御方法、記憶媒体、およびプログラム |
| WO2016178329A1 (ja) * | 2015-05-07 | 2016-11-10 | ソニー株式会社 | 情報処理システム、制御方法、および記憶媒体 |
| CN109844735A (zh) * | 2016-07-21 | 2019-06-04 | 奇跃公司 | 用于使用用户的情感状态控制虚拟图像生成系统的技术 |
| JP6906186B2 (ja) | 2017-07-07 | 2021-07-21 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| EP3650854B1 (en) | 2017-07-07 | 2021-09-15 | Panasonic Intellectual Property Management Co., Ltd. | Information provision method, information processing system, use of an information terminal, and information processing method |
| KR20200024760A (ko) | 2017-07-07 | 2020-03-09 | 파나소닉 아이피 매니지먼트 가부시키가이샤 | 정보 제공 방법, 정보 처리 시스템, 정보 단말, 및 정보 처리 방법 |
| WO2019008973A1 (ja) | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| WO2019008970A1 (ja) | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| JP6924972B2 (ja) | 2017-07-07 | 2021-08-25 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| WO2019008978A1 (ja) | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| CN110022769B (zh) | 2017-07-07 | 2022-09-27 | 松下知识产权经营株式会社 | 信息提供方法、信息处理系统、信息终端及信息处理方法 |
| EP3649949A4 (en) | 2017-07-07 | 2020-09-23 | Panasonic Intellectual Property Management Co., Ltd. | INFORMATION PROVISION METHODS, INFORMATION PROCESSING SYSTEM, INFORMATION TERMINAL DEVICE AND INFORMATION PROCESSING METHODS |
| KR20200024756A (ko) | 2017-07-07 | 2020-03-09 | 파나소닉 아이피 매니지먼트 가부시키가이샤 | 정보 제공 방법, 정보 처리 시스템, 정보 단말, 및 정보 처리 방법 |
| WO2019008972A1 (ja) | 2017-07-07 | 2019-01-10 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| JP6906187B2 (ja) | 2017-07-07 | 2021-07-21 | パナソニックＩｐマネジメント株式会社 | 情報提供方法、情報処理システム、情報端末、及び情報処理方法 |
| JP6301547B1 (ja) * | 2017-11-16 | 2018-03-28 | 朝美 鈴木 | 緊張型頭痛予測システム |
| JP2021035499A (ja) * | 2020-10-14 | 2021-03-04 | 株式会社東芝 | アイウエア、データ収集システム及びデータ収集方法 |
| EP4202578A1 (en) | 2021-12-22 | 2023-06-28 | Swatch Ag | Method and system for keeping a first user and a second user continuously informed of their respective emotional states |
-
2003
- 2003-07-28 JP JP2003280818A patent/JP4389512B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005046305A (ja) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4389512B2 (ja) | 腕時計型会話補助装置、会話補助システム、眼鏡型会話補助装置および会話補助装置 | |
| US11504067B2 (en) | Biometric, physiological or environmental monitoring using a closed chamber | |
| Angelov et al. | Healthcare sensing and monitoring | |
| US20210174778A1 (en) | Biometric, physiological or environmental monitoring using a closed chamber | |
| Sun et al. | A review of recent advances in vital signals monitoring of sports and health via flexible wearable sensors | |
| JP6803299B2 (ja) | システム及び方法 | |
| Li et al. | Recent progress of skin-integrated electronics for intelligent sensing | |
| Rodgers et al. | Recent advances in wearable sensors for health monitoring | |
| US9814425B2 (en) | Health monitoring appliance | |
| AU2014225626B2 (en) | Form factors for the multi-modal physiological assessment of brain health | |
| US8108036B2 (en) | Mesh network stroke monitoring appliance | |
| JP7048709B2 (ja) | システム及び方法 | |
| US20150126825A1 (en) | Physiological Monitoring Apparatus | |
| US20080319282A1 (en) | Patient monitoring apparatus | |
| CN105873503A (zh) | 脉搏波测定装置、便携式设备、医疗设备系统以及生物体信息通信系统 | |
| Neťuková et al. | Lower limb exoskeleton sensors: state-of-the-art | |
| Uniyal et al. | Pervasive healthcare-a comprehensive survey of tools and techniques | |
| He et al. | Toward wearable sensors: advances, trends, and challenges | |
| Gao et al. | Wearable technology for signal acquisition and interactive feedback in autism spectrum disorder intervention: A review | |
| Borboni et al. | EEG-based empathic safe cobot | |
| Lee et al. | Real-time deep learning-assisted mechano-acoustic system for respiratory diagnosis and multifunctional classification | |
| Melders et al. | Recent advances in vehicle driver health monitoring systems | |
| Pachkawade | Bioinspired micro-electromechanical systems/nano-electromechanical systems: an overview, applications, and perspective | |
| Ramasamy et al. | Wearable nanosensor systems and their applications in healthcare | |
| Tsiourti | Artificial agents as social companions: design guidelines for emotional interactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20041224 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060428 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060428 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090401 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090428 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090629 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090915 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090928 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121016 Year of fee payment: 3 |
|
| R151 | Written notification of patent or utility model registration |
Ref document number: 4389512 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121016 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131016 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |